疟疾传播强度可能通过反弹效应改变加纳、马拉维和加蓬的RTS,S/AS01疫苗效力
基于2009—2014年在马拉维利隆圭、加纳金坦波和加蓬兰巴雷内的III期试验(NCT00866619)数据,评估接种组与对照组疟疾发病率随时间及传播强度变化。随时间推移,对照组发病率下降而疫苗组上升;最低传播强度组三剂效力从88.2%降至15.0%,最高传播强度组从81.6%降至-27.7%。作者认为高传播地区应实施包括第四剂RTS,S在内的保护措施。
要点
- 随时间推移,对照组疟疾发病率下降而疫苗组上升。
- 最低传播强度组(0.25例/人年)三剂效力从88.2%降至15.0%。
- 最高传播强度组(3例/人年)三剂效力从81.6%降至-27.7%。
核心结论
- 这些发现提示,在高传播地区应实施包括第四剂RTS,S在内的干预措施,以在潜在反弹期保护接种者。
研究设计与样本
- 使用2009—2014年III期试验(NCT00866619)在马拉维利隆圭、加纳金坦波和加蓬兰巴雷内的数据,估计各疫苗组疟疾发病率随时间及不同传播强度的变化。
- 利用生态变量估计传播强度后,拟合包含疫苗接种、时间和传播强度三阶交互项的模型。
主要发现
- 随时间推移,对照组发病率下降而疫苗组发病率上升。
- 最低传播强度组(0.25例/人年)三剂效力从88.2%降至15.0%,历时4.5年。
- 最高传播强度组(3例/人年)三剂效力从81.6%降至-27.7%。
临床怎么用
- 作者认为,在高传播地区应实施包括第四剂RTS,S在内的干预措施,以在潜在反弹期保护接种者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: RTS,S/AS01 is the first malaria vaccine to be approved and recommended for widespread implementation by the World Health Organization (WHO). Trials reported lower vaccine efficacies in higher-incidence sites, potentially due to a "rebound" in malaria cases in vaccinated children. When naturally acquired protection in the control group rises and vaccine protection in the vaccinated wanes concurrently, malaria incidence can become greater in the vaccinated than in the control group, resulting in negative vaccine efficacies. METHODS: Using data from the 2009-2014 phase III trial (NCT00866619) in Lilongwe, Malawi; Kintampo, Ghana; and Lambaréné, Gabon, we evaluate this hypothesis by estimating malaria incidence in each vaccine group over time and in varying transmission settings. After estimating transmission intensities using ecological variables, we fit models with 3-way interactions between vaccination, time, and transmission intensity. RESULTS: Over time, incidence decreased in the control group and increased in the vaccine group. Three-dose efficacy in the lowest-transmission-intensity group (0.25 cases per person-year [CPPY]) decreased from 88.2% to 15.0% over 4.5 years, compared with 81.6% to -27.7% in the highest-transmission-intensity group (3 CPPY). CONCLUSIONS: These findings suggest that interventions, including the fourth RTS,S dose, that protect vaccinated individuals during the potential rebound period should be implemented for high-transmission settings.
引用
- Bell GJ, Goel V, Essone P, et al. Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon. J Infect Dis. 2022. PMID: 35899811. doi:10.1093/infdis/jiac322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。